Emma Thomas
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Genetics top 5%
- Genetic Associations and Epidemiology
Papers in
-
- COVID-19 Clinical Research Studies 8
-
- Intensive Care Unit Cognitive Disorders 2
- Journals
- JAMA (6 papers)Nature (4 papers)Intensive Care Medicine (4 papers)Critical Care (2 papers)The Lancet (1 paper)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Emma Thomas
19 papers receiving 2.1k citations
Emma Thomas's Hit Papers
Peers
Comparison fields: 5 of 93
- Infectious Diseases 1.2k
- Genetics 507
- Applied Microbiology and Biotechnology 33
- Emergency Medicine 85
- Neurology 99
Countries citing papers authored by Emma Thomas
This map shows the geographic impact of Emma Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Thomas more than expected).
Fields of papers citing papers by Emma Thomas
This network shows the impact of papers produced by Emma Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Thomas. The network helps show where Emma Thomas may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 2 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 3 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 233 |
| 4 | 2021 | 166 | |
| 5 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 125 |
| 6 | 2022 | 105 | |
| 7 | 2022 | 100 | |
| 8 | 2021 | 72 | |
| 9 | 2023 | 60 | |
| 10 | 2022 | 54 | |
| 11 | 2023 | 46 | |
| 12 | 2022 | 45 | |
| 13 | 2023 | 34 | |
| 14 | 2024 | 26 | |
| 15 | Dexmedetomidine- or Clonidine-Based Sedation Compared With Propofol in Critically Ill Patients Hit paper breakdown → | 2025 | 17 |
| 16 | 2024 | 8 | |
| 17 | 2025 | 1 | |
| 18 | 2025 | 1 | |
| 19 | 2026 | 1 |
About Emma Thomas
Emma Thomas is a scholar working on Infectious Diseases, Critical Care and Intensive Care Medicine, Emergency Medicine, Genetics and Anesthesiology and Pain Medicine, having authored 19 papers that have together received 2.2k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (8 papers), Genetic Associations and Epidemiology (5 papers), Cardiac Arrest and Resuscitation (3 papers), Anesthesia and Sedative Agents (2 papers), Intensive Care Unit Cognitive Disorders (2 papers), Vitamin C and Antioxidants Research (1 paper), Acute Kidney Injury Research (1 paper) and Traumatic Brain Injury and Neurovascular Disturbances (1 paper). The work is most often cited by research in Infectious Diseases (1.2k citations), Genetics (507 citations), Applied Microbiology and Biotechnology (33 citations), Emergency Medicine (85 citations) and Neurology (99 citations). Emma Thomas has collaborated with scholars based in United Kingdom, Australia and United States. Their work appears in journals such as JAMA, Nature, Intensive Care Medicine, Critical Care and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.